Shire (SHPGY) Will Hand Pink Slips to 600 Employees in Pennsylvania
AbbVie (ABBV) Outbids Johnson & Johnson (JNJ) and Lands Pharmacyclics (PCYC) for $21 Billion
Mallinckrodt (MNK) Forks Out $2.3 Billion for Respiratory Drug and Device Maker Ikaria
Bristol-Myers Squibb (BMY) Grabs Record Fast Approval for Opdivo
Stanford University Spinout Alkahest Lands $37.5 Million Investment
Novartis AG (NVS) Unloads RNAi Portfolio to Arrowhead Research Corporation (ARWR) for $35 Million
Backed By Investors Like Ex-Genzyme (GENZ) CEO, Aura Biosciences Locks In $21 Million
Orexigen (OREX)'s Failure to Keep a Lid on it Prompts the FDA to Force a Second Study
After Turning Down Sanofi (SAN.PA) Gig, Takeda (TKPYY) COO Gets Promoted to CEO
Bristol-Myers Squibb (BMY) Bets $975 Million on Bavarian Nordic (BAVA.CO)'s Prostate Cancer Vaccine
Novartis AG (NVS) Will Move Past Scandal While Hunting for More M&A in the $2-5 Billion Range, Says CEO
Malin, Formed by Ex-Elan (ELN) Execs, Eye Up to $365 Million in Biotech IPO
Baxter International (BAX) Snaps Up German Biopharma for $225 Million
Poll Result for Best Hair In BioPharma Crown Receptos (RCPT)'s Hasnain King
Analyst: Docs Bullish On Roche (RHHBY)'s Perjeta and PD-1/PDL1, Cautious on Palbociclib and Neratinib
Backed By a Genentech (RHHBY) Alum, NGM Looks Like it Could be the Next Biotech IPO
CALBIO15: Johnson & Johnson (JNJ) Unveils New Innovation Center, Looks to Spark Creative Revolution in the Bay: Exec
Genentech (RHHBY)'s Controversial Distribution Move Deemed a Failure: Survey
See All News >
//-->